Leukemia, Philadelphia chromosome-positive, resistant to imatinib: genes and variants
Explore variant evidence for Leukemia, Philadelphia chromosome-positive, resistant to imatinib across 1 analyzed protein (ABL1). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-10. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Leukemia, Philadelphia chromosome-positive, resistant to imatinib
ABL1: Tyrosine-protein kinase ABL1
It coordinates cytoskeletal remodeling, adhesion, DNA-damage responses, and growth signaling through tightly regulated tyrosine phosphorylation. Fusion with BCR removes normal control and creates the constitutively active kinase that drives chronic myeloid leukemia and subsets of acute lymphoblastic leukemia.
5 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ABL1 have source records linked to Leukemia, Philadelphia chromosome-positive, resistant to imatinib. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Leukemia, Philadelphia chromosome-positive, resistant to imatinib
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ABL1 E255K | 255 | Protein kinase | Pathogenic / likely pathogenic |
| ABL1 E255V | 255 | Protein kinase | Pathogenic / likely pathogenic |
| ABL1 Y253H | 253 | Protein kinase | Pathogenic / likely pathogenic |
| ABL1 E236K | 236 | Pathogenic / likely pathogenic | |
| ABL1 E236V | 236 | Pathogenic / likely pathogenic |
Same protein, different disease
- Congenital heart defects and skeletal malformations syndrome also has ClinVar records linked to ABL1 variants; they fall mostly in different places as the Leukemia, Philadelphia chromosome-positive, resistant to imatinib variants (14 pathogenic / likely pathogenic).
- Chronic myeloid leukemia also has ClinVar records linked to ABL1 variants; they fall mostly in different places as the Leukemia, Philadelphia chromosome-positive, resistant to imatinib variants (3 pathogenic / likely pathogenic).
Diseases related to Leukemia, Philadelphia chromosome-positive, resistant to imatinib
- Gastrointestinal stromal tumor, also linked to ABL1
- Colorectal cancer, also linked to ABL1
- Congenital heart defects and skeletal malformations syndrome, also linked to ABL1
- Heart disease, also linked to ABL1
- Microcephaly, also linked to ABL1
- Acute lymphoid leukemia, also linked to ABL1
- Lip and oral cavity carcinoma, also linked to ABL1
- Chronic myeloid leukemia, also linked to ABL1
Frequently asked questions
Which genes have records linked to Leukemia, Philadelphia chromosome-positive, resistant to imatinib?
This view contains 1 analyzed proteins: ABL1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 5 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center